Increased rate of recurrence and high rate of salvage in patients with human papillomavirus–associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapy

Some patients with human papillomavirus (HPV)–associated oropharyngeal squamous cell carcinoma (OPSCC) do not receive guideline‐recommended postoperative radiation therapy (PORT) following primary transoral robotic surgery (TORS).

[1]  E. Mendez,et al.  Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311). , 2020 .

[2]  G. Weinstein,et al.  Pharyngeal‐sparing radiation for head and neck carcinoma of unknown primary following TORS assisted work‐up , 2020, The Laryngoscope.

[3]  K. Higgins,et al.  National treatment trends in human papillomavirus–positive oropharyngeal squamous cell carcinoma , 2019, Cancer.

[4]  G. Weinstein,et al.  A Phase II Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed Following Transoral Robotic Surgery for Human Papilloma Virus Related Squamous Cell Carcinoma of the Oropharynx. , 2019, International journal of radiation oncology, biology, physics.

[5]  G. Weinstein,et al.  The impact of treatment package time on locoregional control for HPV+ oropharyngeal squamous cell carcinoma treated with surgery and postoperative (chemo)radiation , 2019, Head & neck.

[6]  D. Kallogjeri,et al.  Long‐term analysis of transorally resected p16 + Oropharynx cancer: Outcomes and prognostic factors , 2018, The Laryngoscope.

[7]  A. Walch,et al.  Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck – clinical results from the cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer” , 2018, Radiation Oncology.

[8]  G. Weinstein,et al.  Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional Review. , 2017, International journal of radiation oncology, biology, physics.

[9]  E. Sturgis,et al.  Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline. , 2017, Practical radiation oncology.

[10]  Joshua M Bauml,et al.  Transoral Robotic Surgery–Assisted Endoscopy With Primary Site Detection and Treatment in Occult Mucosal Primaries , 2017, JAMA otolaryngology-- head & neck surgery.

[11]  Y. An,et al.  De-intensification of adjuvant therapy in human papillomavirus-associated oropharyngeal cancer , 2016, Cancers of the Head & Neck.

[12]  C. Fakhry,et al.  The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer , 2016, The Laryngoscope.

[13]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[14]  F. Wrba,et al.  Improved survival in HPV/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapy , 2015, Strahlentherapie und Onkologie.

[15]  M. Verma,et al.  Current trends in the etiology and diagnosis of HPV-related head and neck cancers , 2015, Cancer medicine.

[16]  V. Budach,et al.  HPV in , 2014 .

[17]  K. Ang,et al.  Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. , 2012, International journal of radiation oncology, biology, physics.

[18]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[19]  J. Califano,et al.  Cystic lymph node metastasis in patients with head and neck cancer: An HPV‐associated phenomenon , 2008, Head & neck.

[20]  G. Weinstein,et al.  Transoral robotic surgery: radical tonsillectomy. , 2007, Archives of otolaryngology--head & neck surgery.

[21]  G. Weinstein,et al.  Transoral Robotic Surgery (TORS) for Base of Tongue Neoplasms , 2006, The Laryngoscope.

[22]  D. Rimm,et al.  Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. van Glabbeke,et al.  Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) , 2005, Head & neck.

[24]  J. Jacobs,et al.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.

[25]  K. Shah,et al.  Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[27]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[28]  J. Waldron,et al.  Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[29]  Jacques Bernier,et al.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.

[30]  F. Greene,et al.  AJCC cancer staging handbook : from the AJCC cancer staging manual , 2002 .